View on Pubmed.gov 31168386 | View on doi.org 10.1136/openhrt...
Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias.
- Geneeskunde en farmacie, Vrije Universiteit Brussel, Brussel, Belgium.
- Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
- Centrum voor Hart- en Vaatziekten, UZ Brussel, Brussels, Belgium.
- Institute for Clinical Medicine, Universitetet i Oslo, Oslo, Norway.
- Department of Radiology and Nuclear Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
- The Intervention Centre, Oslo universitetssykehus Rikshospitalet, Oslo, Norway.
- Radiology (MRI), Uz Brussel, Jette, Belgium.
- Research Institute of Internal Medicine, Oslo Universisty Hospital, Rikshospitalet, Oslo, Norway.
- Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Abstract
Objective
Displacement of the mitral valve, mitral annulus disjunction (MAD), is described as a possible aetiology of sudden cardiac death. Stress-induced fibrosis in the mitral valve apparatus has been suggested as the underlying mechanism. We aimed to explore the association between stretch-related and fibrosis-related biomarkers and ventricular arrhythmias in MAD. We hypothesised that soluble suppression of tumourigenicity-2 (sST2) and transforming growth factor-β1 (TGFβ1) are markers of ventricular arrhythmias in patients with MAD.
Methods
We included patients with ≥1 mm MAD on cardiac MRI. We assessed left ventricular ejection fraction (LVEF) and fibrosis by late gadolinium enhancement (LGE). The occurrence of ventricular arrhythmia, defined as aborted cardiac arrest, sustained or non-sustained ventricular tachycardia, was retrospectively assessed. We assessed circulating sST2 and TGFβ1 levels.
Results
We included 72 patients with MAD, of which 22 (31%) had ventricular arrhythmias. Patients with ventricular arrhythmias had lower LVEF (60 % (±6) vs 63% (±6), p = 0.04), more frequently papillary muscle fibrosis (14 (64%) vs 10 (20%), p < 0.001) and higher sST2 levels (31.6 ± 10.1 ng/mL vs 25.3 ± 9.2 ng/mL, p = 0.01) compared with those without, while TGFβ1 levels did not differ (p = 0.29). Combining sST2 level, LVEF and papillary muscle fibrosis optimally detected individuals with arrhythmia (area under the curve 0.82, 95% CI 0.73 to 0.92) and improved the risk model (p < 0.05) compared with single parameters.
Conclusion
Circulating sST2 levels were higher in patients with MAD and ventricular arrhythmias compared with arrhythmia-free patients. Combining sST2, LVEF and LGE assessment improved risk stratification in patients with MAD.
References
N Engl J Med. 1999 Jul 1;341(1):1-7
Circulation. 2002 Dec 3;106(23):2961-6
Eur Heart J. 2004 Apr;25(8):680-7
J Clin Invest. 2007 Jun;117(6):1538-49
Cited by 25 citations (total)
Journal Article Review
Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death.
Electronic publication date February 26, 2020
Zornitsa Shomanova [...] Lukas J Motloch et al.
Sudden cardiac death (SCD), most often induced by ventricular arrhythmias, is one of the main reasons for cardiovascular-related mortality. While...
Journal Article Review
Developing a Mechanistic Approach to Sudden Death Prevention in Mitral Valve Prolapse.
Electronic publication date March 11, 2022
Brian P Kelley [...] Faisal F Syed et al.
Sudden cardiac death (SCD) from ventricular fibrillation (VF) can occur in mitral valve prolapse (MVP) in the absence of other...
Conflict of interest statement
Competing interests: None declared.
MeSH
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •